In this interview, Dr. Qing Wang, Founder and CEO, discusses how Complete Omics is leveraging multiomics to develop comprehensive, low-cost screening assays to cover a large range of human diseases, including all human cancers. Hear how Complete Omics is also working alongside pharmaceutical companies to develop personalized neoantigen assays for companion diagnostics.